The role of general practitioners in migraine management

Cephalalgia : an International Journal of Headache
Michel Lantéri-Minet

Abstract

General practitioners (GPs) play a pivotal role in managing migraine and ensuring that patients have a positive first experience when seeking treatment. A large proportion of migraineurs do not consult a GP, preferring to rely on over-the-counter remedies to reduce pain and disability. For those who do consult, receiving a satisfactory outcome at their first consultation is important for ensuring subsequent effective management of their migraine. If patient expectations are not met at their first visit (prescribed treatment is ineffective or GP does not empathize with their suffering), patients may not return for further consultation. There remains a need to improve migraine diagnosis and treatment, and GPs require continuing medical education and neurologist support to ensure that they are providing the best migraine treatments and outcomes. More widespread use of diagnostic tools, standardized management guidelines and individualized treatment regimens will help GPs successfully manage both migraine symptoms and patient expectations.

References

Jul 17, 1998·Headache·R Smith
Oct 16, 1999·Comprehensive Therapy·R BerlinerR B Lipton
Nov 22, 2000·JAMA : the Journal of the American Medical Association·R B LiptonUNKNOWN Disability in Strategies of Care Study group
Mar 2, 2002·Current Pain and Headache Reports·Thais Brown TonoreSara L Noble
Apr 23, 2002·Headache·Richard B LiptonJeffrey M Dayno
Jul 26, 2002·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·John Edmeads
Aug 13, 2003·Neurology·R B LiptonUNKNOWN ID Migraine validation study
Dec 4, 2003·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M KosinskiS Tepper
May 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·J Olesen, T J Steiner
May 25, 2004·Cephalalgia : an International Journal of Headache·M Linde, C Dahlöf
Sep 29, 2004·PharmacoEconomics·André PradalierAnne-François Gaudin
Feb 4, 2005·Cephalalgia : an International Journal of Headache·E Vuillaume De Diego, M Lanteri-Minet
Mar 19, 2005·Cephalalgia : an International Journal of Headache·C LucasM Lantéri-Minet
Apr 19, 2005·Headache·Richard B Lipton, Marcelo E Bigal
Apr 22, 2005·The American Journal of Medicine·Merle Diamond, Roger Cady
Apr 22, 2005·The American Journal of Medicine·Vincent T Martin, James A Goldstein
Jul 28, 2005·Journal of the American Academy of Nurse Practitioners·Fred D SheftellCarolyn C Hart
Nov 25, 2005·Cephalalgia : an International Journal of Headache·M Lantéri-MinetC Lucas
Apr 29, 2006·Headache·Shahram N MalikStephen D Silberstein
Jun 21, 2006·Expert Review of Neurotherapeutics·Merle L DiamondGeorge R Nissan
Mar 27, 2007·Cephalalgia : an International Journal of Headache·Lj StovnerJ-A Zwart
Apr 4, 2007·Cephalalgia : an International Journal of Headache·L Kelman
Apr 12, 2007·Headache·Richard B Lipton, Marcelo E Bigal
Sep 25, 2007·Cephalalgia : an International Journal of Headache·M Lantéri-MinetA El Hasnaoui
Jul 23, 2008·Cephalalgia : an International Journal of Headache·F RadatM Lantéri-Minet

❮ Previous
Next ❯

Citations

Jun 1, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G GianniniS Cevoli
Aug 14, 2009·Cephalalgia : an International Journal of Headache·R W EvansH J Kell
Jan 25, 2014·European Neurology·Raquel Gil-Gouveia
Apr 23, 2014·Current Opinion in Neurology·Anders HougaardMessoud Ashina
Nov 7, 2009·The Journal of Headache and Pain·Gereon NellesUNKNOWN TOPMATMIG-0001 investigators
Jul 27, 2012·Cephalalgia : an International Journal of Headache·Daisy S Ng-MakMontse Roset
Jul 31, 2012·Cephalalgia : an International Journal of Headache·R ZielmanJsp van den Berg
Oct 22, 2015·Cephalalgia : an International Journal of Headache·Petra VeenstraJs Peter van den Berg

❮ Previous
Next ❯

Software Mentioned

MIDAS
ID

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Headache
Richard B Lipton, Marcelo E Bigal
Neurología : publicación oficial de la Sociedad Española de Neurología
J PascualJ Castillo
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
M WoloshynowychP Salmon
© 2022 Meta ULC. All rights reserved